<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 58-year-old woman was admitted at diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> without keto-<z:hpo ids='HP_0001941'>acidosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Blood <z:chebi fb="105" ids="17234">glucose</z:chebi> was normalized initially with insulin </plain></SENT>
<SENT sid="2" pm="."><plain>Whilst taking <z:chebi fb="0" ids="5441">glibenclamide</z:chebi>, she developed <z:hpo ids='HP_0011009'>acute</z:hpo> haemolysis </plain></SENT>
<SENT sid="3" pm="."><plain>She was homozygous for <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphate dehydrogenase (G6PD) deficiency and had no other factors predisposing haemolysis </plain></SENT>
<SENT sid="4" pm="."><plain>We reviewed the literature and discuss the relationship between <z:chebi fb="0" ids="5441">glibenclamide</z:chebi> and haemolytic crisis and between <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G6PD-deficiency</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>